Ovarro Appoints New UK Sales Director

Those water companies getting on the front foot with leakage targets and technology investment now will be in a strong position going into AMP8, writes Paul Hartley, chief commercial officer, Ovarro.

At the British Water Micropollutants Conference 2024, which took place in London on 8 February, keynote speakers from the UK’s Environment Agency called for a cross-industry approach to tackling the issue.

Installation of 320 Ovarro remote correlating loggers has taken place in Davao City in the Philippines, with a major leak detected just days later. The volume of water saved means a large-scale project to construct a new production well can be put on hold. Davao is the largest city on the island of Mindanao and the third largest in the Philippines. With a rapidly increasing population, the city is considered one of the country’s fastest economic growth areas.

Three UK water utilities have agreed orders for the installation of a total of 30 Hybrid-SAF modular biological treatment units from wastewater treatment specialist WCS Environmental Engineering (WCSEE). The contracts with Anglian Water, Scottish Water, and United Utilities demonstrate growing demand for this adaptable wastewater treatment technology that gives utilities greater flexibility in meeting the needs of growing populations and tightening regulatory standards.

Using cloud-based platforms for more efficient leak detection will be the subject of an Ovarro presentation at the Philippine Association of Water Districts (PAWD) annual convention. Channel manager Craig Abbott will highlight Ovarro cloud solutions that analyse network noise to provide actionable information for leakage reduction.

Technology company Ovarro has partnered with UK Water Industry Research (UKWIR) to update the sector on advancements in non-acoustic leak detection techniques. The update provides an overview of the current non-acoustic methods that have been trialled and deployed since 2016, when a first iteration of the study was published, and their relative cost and effectiveness. The report identifies successful applications, potential deployment pitfalls and best practice guidance for trials.